Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00796861 · ClinicalTrials.gov registry record · Phase 2
Trial of Sunitinib for Refractory Malignant Ascites
A Phase 2 study, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT00796861 is a Phase 2 study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 4 participants.
The verdict
NCT00796861, a Phase 2 study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
The study is to see whether treatment with Sunitinib decreases the accumulation of ascites in patients with refractory malignant ascites.
Interventions
- DRUG Sunitinib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2007-05 |
| Est. Completion | 2011-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00796861
The ClinicalTrials.gov registry entry for NCT00796861 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sunitinib is the first listed.
NCT00796861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00796861 about?
NCT00796861 is a clinical study titled "Trial of Sunitinib for Refractory Malignant Ascites". The study is to see whether treatment with Sunitinib decreases the accumulation of ascites in patients with refractory malignant ascites.
What is the current status of trial NCT00796861?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2007-05. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00796861?
The interventions under investigation include: Sunitinib (DRUG).
Who is sponsoring clinical trial NCT00796861?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.